Insufficient scRNA-seq data for expression of IL36G at single-cell level.
Insufficient scRNA-seq data for expression of IL36G at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
tonsil | 0% | 0 | 0 / 0 | 89% | 55.68 | 40 / 45 |
skin | 71% | 801.10 | 1282 / 1809 | 8% | 1.42 | 37 / 472 |
esophagus | 23% | 222.47 | 333 / 1445 | 54% | 43.10 | 99 / 183 |
uterus | 0% | 0 | 0 / 170 | 42% | 24.60 | 194 / 459 |
lung | 0% | 0.16 | 1 / 578 | 37% | 17.53 | 430 / 1155 |
bladder | 0% | 0 | 0 / 21 | 17% | 5.93 | 87 / 504 |
pancreas | 0% | 0 | 0 / 328 | 7% | 0.64 | 12 / 178 |
intestine | 0% | 0.11 | 1 / 966 | 5% | 0.93 | 26 / 527 |
thymus | 0% | 0 | 0 / 653 | 3% | 0.26 | 21 / 605 |
breast | 0% | 0 | 0 / 459 | 2% | 0.10 | 17 / 1118 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.05 | 3 / 286 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.02 | 3 / 430 |
liver | 0% | 0.34 | 1 / 226 | 0% | 0 | 0 / 406 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.01 | 3 / 705 |
muscle | 0% | 0.33 | 3 / 803 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.92 | 2 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.32 | 2 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.24 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0002437 | Biological process | inflammatory response to antigenic stimulus |
GO_0007267 | Biological process | cell-cell signaling |
GO_0045087 | Biological process | innate immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005125 | Molecular function | cytokine activity |
GO_0005149 | Molecular function | interleukin-1 receptor binding |
Gene name | IL36G |
Protein name | Interleukin-36 gamma (IL-1-related protein 2) (IL-1RP2) (Interleukin-1 epsilon) (IL-1 epsilon) (Interleukin-1 family member 9) (IL-1F9) (Interleukin-1 homolog 1) (IL-1H1) Interleukin 36 gamma |
Synonyms | IL1F9 IL1H1 UNQ2456/PRO5737 IL1E IL1RP2 |
Description | FUNCTION: Cytokine that binds to and signals through the IL1RL2/IL-36R receptor which in turn activates NF-kappa-B and MAPK signaling pathways in target cells. Part of the IL-36 signaling system that is thought to be present in epithelial barriers and to take part in local inflammatory response; similar to the IL-1 system with which it shares the coreceptor IL1RAP. Seems to be involved in skin inflammatory response by acting on keratinocytes, dendritic cells and indirectly on T-cells to drive tissue infiltration, cell maturation and cell proliferation. In cultured keratinocytes induces the expression of macrophage, T-cell, and neutrophil chemokines, such as CCL3, CCL4, CCL5, CCL2, CCL17, CCL22, CL20, CCL5, CCL2, CCL17, CCL22, CXCL8, CCL20 and CXCL1; also stimulates its own expression and that of the prototypic cutaneous pro-inflammatory parameters TNF-alpha, S100A7/psoriasin and inducible NOS. May play a role in pro-inflammatory responses during particular neutrophilic airway inflammation: activates mitogen-activated protein kinases and NF-kappa B in primary lung fibroblasts, and stimulates the expression of IL-8 and CXCL3 and Th17 chemokine CCL20 in lung fibroblasts. May be involved in the innate immune response to fungal pathogens, such as Aspergillus fumigatus. . |
Accessions | C9J681 ENST00000259205.5 [Q9NZH8-1] ENST00000376489.6 [Q9NZH8-2] Q9NZH8 ENST00000447128.5 |